-+ 0.00%
-+ 0.00%
-+ 0.00%

Puma Biotechnology Sees Q2 Sales $48.000M-$50.000M vs $52.75M Est

Benzinga·05/08/2025 20:23:11
Listen to the news
Puma Biotechnology (NASDAQ:PBYI) sees Q2 sales of $48.000 million-$50.000 million vs $52.75 million analyst estimate.